Tuesday, January 10, 2017

UPDATE 3-Valeant to sell assets for $2.12 bln to ease debt load

Jan 10 (Reuters) - Valeant Pharmaceuticals International

is selling its Dendreon cancer treatment business and

three skincare brands for $2.12 billion as the troubled Canadian

drugmaker looks to...

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)